Suchergebnisse - "Balmaña, J"

PubPharm (94)

1

Incorporating alternative Polygenic Risk Scores into the BOADICEA breast cancer risk prediction model

enthalten in: bioRxiv.org | 2024

von Mavaddat, N. | Ficorella, L. | Carver, T. | +22

2

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Harvey-Jones, E. | Raghunandan, M. | Robbez-Masson, L. | +36

3

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes : ESMO Clinical Practice Guideline

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Sessa, C. | Balmaña, J. | Bober, S. | +16

4

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Geyer, C. | Garber, J. | Gelber, R. | +174

5

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer : original article

enthalten in: Annals of oncology | 28 November 2022

von Geyer, C. | Garber, J. | Gelber, R. | +73

6

Post-hematopoietic stem cell transplant squamous cell carcinoma in patients with Fanconi anemia : a dreadful enemy

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2022

von Murillo-Sanjuán, L. | Balmaña, J. | de Pablo García-Cuenca, A. | +4

7

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer

enthalten in: ESMO open | 2021

von Condorelli, M. | Bruzzone, M. | Ceppi, M. | +38

8

Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC) : analysis of the GeparSixto randomized clinical trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Llop-Guevara, A. | Loibl, S. | Villacampa, G. | +18

9

Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC) : analysis of the GeparSixto randomized clinical trial

enthalten in: Annals of oncology | 11 September 2021

von Llop-Guevara, A. | Loibl, S. | Villacampa, G. | +18

10

Post-hematopoietic stem cell transplant squamous cell carcinoma in patients with Fanconi anemia: a dreadful enemy

enthalten in: Clinical & translational oncology | 2021

von Murillo-Sanjuán, L. | Balmaña, J. | de Pablo García-Cuenca, A. | +4

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]